Altamira Therapeutics Ltd.: xbrl:AccountingProfit

Value{"unit": "CHF", "value": -24427247}
Period2017-01-01 – 2017-12-31
Statuscurrent
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001601936-18-000007
Retrieved: 2026-08-19T16:24:22.861909+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/4e52d1f4-a456-4704-be4d-c253c3ec7a35

History